Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials

Vetter, ML; Johnsson, K; Hardy, E; Wang, H; Iqbal, N

Johnsson, K (reprint author), AstraZeneca, Molndal, Sweden.

DIABETES THERAPY, 2019; 10 (4): 1249

Abstract

IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for treatment of type 2 diabetes mellitus; however, there have been c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索